• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Two ARVO members tapped for board

Article

Rockville, MD—Two members of the Association for Research in Vision and Ophthalmology (ARVO) have been elected to its board of trustees.

Rockville, MD-Two members of the Association for Research in Vision and Ophthalmology (ARVO) have been elected to its board of trustees.

Nicholas A. Delamere, PhD, and Paul Sternberg Jr., MD, were elected during the 2005 ARVO annual meeting in Fort Lauderdale, FL, in May.

Dr. Delamere will serve a 5-year term as physiology/pharmacology trustee. He is a professor of ophthalmology and visual sciences and pharmacology and toxicology at the University of Louisville, Louisville, KY.

Dr. Sternberg, who will serve a 5-year term as retina trustee, is the George W. Hale Professor and Chair of the Vanderbilt Eye Institute. His laboratory studies the pathogenesis of age-related macular degeneration. He serves as the American Academy of Ophthalmology's secretary of communications and is a member of the National Eye Institute's Board of Scientific Councilors.

ARVO's membership includes more than 11,300 eye and vision researchers in 70 countries.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.